Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Late surfactant and recruitment maneuver in ELGANs
NCT04825197Phase 2Unknown
- Start
- Dec 2021
- Primary completion
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Poractant alfa in bronchopulmonary dysplasia (BPD), chronic pulmonary insufficiency of prematurity (CPIP). Status: unknown.
02
Drugs
Poractant alfa
03
Conditions
bronchopulmonary dysplasia (BPD)chronic pulmonary insufficiency of prematurity (CPIP)
Beyond the preview
Go deeper on NCT04825197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04825197.